Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
638.00    9.40 (1.50%)
Bid:
635.20
Ask:
635.40
Spread: 0.20 (0.031%)
Market Cap: £50.78b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Director/PDMR Shareholding

10 Nov 2022 15:53

RNS Number : 0384G
NatWest Group plc
10 November 2022
 

10 November 2022

 

NatWest Group plc

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) in accordance with Article 19 of the Market Abuse Regulation

 

1. NatWest Group plc (the Company) announces that ordinary shares of £1.0769* each in the Company (Shares) (ISIN:GB00BM8PJY71) were delivered to PDMRs on 7 November 2022, under the NatWest Group 2014 Employee Share Plan (the Plan), as set out below. 

 

The Shares delivered represent payment of a fixed share allowance (FSA) for the three month period ending 31 December 2022 and have been calculated using a Share price of £2.3316.

 

The number of Shares delivered, the number of Shares withheld to meet associated tax liabilities and the number of Shares retained by each PDMR is as follows:-

 

Name of PDMR

Position of PDMR

No. of Shares delivered

No. of Shares withheld to satisfy associated tax liability

 

No. of Shares retained

 

Robert Begbie

 

 

CEO, NatWest Markets

16,084

7,732

8,352

 

Peter Flavel

 

 

CEO, Wealth Businesses

26,806

12,618

14,188

 

Bruce Fletcher

 

Chief Risk Officer, NatWest Group

 

35,920

16,908

19,012

 

David Lindberg

 

 

CEO, Retail Banking

34,848

16,404

18,444

 

Scott Marcar

 

Chief Information Officer

 

57,633

27,129

30,504

 

 

Andrew McLaughlin

 

 

CEO, Commercial & Institutional for the non-ring-fenced bank

 

2,145

1,010

1,135

 

Katie Murray

 

Chief Financial Officer

 

82,026

38,611

43,4151

 

Alison Rose

 

 

Chief Executive Officer

 

120,304

56,628

63,6761

 

 

John-Paul Thwaite

 

CEO, Commercial & Institutional for the ring-fenced bank

 

33,508

15,773

17,735

 

Jen Tippin

 

Chief People & Transformation Officer

 

44,230

20,820

23,410

1. The shares will be released in instalments over a five year period.

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share

 

The market price used to determine the number of Shares withheld to meet associated tax liabilities was £2.3812. Shares retained after payment of associated tax liabilities will be held on behalf of PDMRs in the Computershare Share Plan Account and will be released in instalments over a three year period, unless otherwise indicated above.

 

2. The Company also announces that it has been notified of the PDMR set out below selling Shares on the date and at the price indicated:

 

Name of PDMR

Position of PDMR

No. of Shares sold

Price of Shares sold

 

Date Shares sold

 

Alison Rose

 

Chief Executive Officer

 

 

250,000

 

£2.3910

 

10 November 2022

 

 

3. The Company also announces that on 7 November 2022, a conditional Buy-out award (Award) was granted under the Plan to the PDMR set out below in order to replace awards forfeited by the individual on leaving their previous employer.

 

Name of PDMR

Position of PDMR

Award price

No. of Shares granted

Scott Marcar

Chief Information Officer

£2.61692

581,681

 

2. The Award price has been calculated using a 5 day average Share price taken immediately prior to the PDMR joining the Company.

 

 

 

The above transactions took place on the London Stock Exchange (XLON).

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

For further information contact:-

 

NatWest Group Investor RelationsAlexander Holcroft

Head of Investor Relations+44(0)20 7672 1758

 

NatWest Group Media Relations 

+44(0)131 523 4205

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFFISEESEIF
Date   Source Headline
31st Jan 20253:33 pmRNSTotal Voting Rights
28th Jan 202510:30 amRNSHolding(s) in Company – HMT shareholding
14th Jan 202510:30 amRNSHolding(s) in Company - HMT shareholding
3rd Jan 20252:00 pmRNSDirector/PDMR Shareholding
31st Dec 20241:06 pmRNSTotal Voting Rights
13th Dec 202411:15 amRNSAppointment of Chief Governance Officer
13th Dec 202410:30 amRNSHolding(s) in Company - HMT
13th Dec 20249:00 amRNSDirectorate Change
6th Dec 20241:47 pmRNSPublication of Prospectus
29th Nov 202412:44 pmRNSTotal Voting Rights
26th Nov 20242:00 pmRNSDirector/PDMR Shareholding
22nd Nov 202410:30 amRNSHolding(s) in Company – HMT shareholding
21st Nov 202410:10 amRNSHolding(s) in Company Capital Group Companies Inc.
18th Nov 20244:24 pmRNSDividend Declaration
18th Nov 20243:00 pmRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSNatWest Group plc Filing of Registration Statement
13th Nov 20241:36 pmRNSHolding(s) in Company - HMT Shareholding
13th Nov 20241:11 pmRNSTotal Voting Rights
12th Nov 20242:00 pmRNSDirector/PDMR Shareholding
12th Nov 20247:00 amRNSQ3 2024 Pillar 3
11th Nov 20247:01 amRNSOff-Market Purchase of Ordinary Shares from HMT
11th Nov 20247:00 amRNSDisposal of Shares in NatWest Group plc for £1bn
8th Nov 20242:00 pmRNSDirector/PDMR Shareholding
6th Nov 20241:18 pmRNSNotice of Redemption
31st Oct 20241:02 pmRNSTotal Voting Rights
31st Oct 202410:30 amRNSHolding(s) in Company -HMT
25th Oct 20243:58 pmRNSPublication of Supplementary Prospectus
25th Oct 20247:00 amRNSNWG plc Q3 Results 2024
9th Oct 202410:30 amRNSHolding(s) in Company -HMT
2nd Oct 20244:00 pmRNSDirector/PDMR Shareholding
2nd Oct 202410:57 amRNSBlock Listing Six Monthly Return
30th Sep 20241:07 pmRNSTotal Voting Rights
27th Sep 202412:30 pmRNSDirector Declaration
26th Sep 20241:47 pmRNSNotice of Redemption
24th Sep 20248:00 amRNSBank of America Financials CEO Conference
23rd Sep 202410:30 amRNSHolding(s) in Company - HMT
17th Sep 20244:00 pmRNSDirector/PDMR Shareholding
13th Sep 20244:57 pmRNSPublication of Final Terms
11th Sep 20249:30 amRNSDirector Declaration
10th Sep 20246:02 pmRNSPublication of Final Terms
10th Sep 20243:00 pmRNSDirector/PDMR Shareholding
10th Sep 202412:00 pmRNSBarclays Global Financial Services Conference
30th Aug 202411:31 amRNSTotal Voting Rights
30th Aug 202410:30 amRNSHolding(s) in Company - HMT
13th Aug 202412:05 pmRNSNatWest Group plc Filing of Registration Statement
13th Aug 20247:18 amRNSH1 2024 Pillar 3
13th Aug 20247:00 amRNSQ1 2024 Pillar 3
8th Aug 20244:00 pmRNSDirector/PDMR Shareholding
7th Aug 202410:39 amRNSHolding(s) in Company - Norges Bank
6th Aug 20247:20 amRNS2024 NatWest Group resolvability assessment report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.